Jin Lee, MD Joins Astera Cancer Care
Astera Cancer Care, an independent and physician-owned multi-specialty community oncology practice serving 12,000 new patients annually in New Jersey, is proud to announce the addition of board-certified hematologist-oncologist, Jin Lee, MD. Dr. Lee will practice at 201 State Rt 17N Fl, 11, Rutherford, NJ 07070.
Dr. Lee was inspired to pursue medicine after his father experienced GI bleeding. “I remember how the nurses and my father’s gastroenterologist reassured my family and thoroughly explained what happened, his treatment, and how to prevent it in the future,” he said. “I wanted to help and comfort people in their time of need. Reassurance and kind gestures can sometimes make all the difference.”
Dr. Lee received his Doctor of Medicine from the Medical College of Georgia. He completed an internship in general surgery at Hahnemann University Hospital and a residency in internal medicine at Allegheny General Hospital. In addition, he completed a fellowship in hematology-oncology at the University of Pittsburgh Medical Center.
“I follow one rule—The Golden Rule,” Dr. Lee said. “I believe that each person is unique and requires individual attention and care. I must always respect their cultures, beliefs, and opinions.”
Dr. Lee will be practicing alongside Dr. Giuseppe Condemi in Rutherford. Their combined skills and expertise will continue to enhance Astera Cancer Care’s commitment to providing comprehensive patient-centered care.
“I am thrilled to continue my pursuit of healing at Astera Cancer Care,” he said. “Astera understands the needs of medical professionals and patients, providing comprehensive resources and access to clinical trials.”
Dr. Lee is fluent in English and Korean.
To make an appointment, please call (732) 390-7750. For more information, visit AsteraCancerCare.org.
About Astera Cancer Care
Astera Cancer Care is an independent and physician-owned multi-specialty community oncology practice serving Central Jersey. Astera Cancer Care inspires hope and improves outcomes through its commitment to personalized patient care and the latest treatment and research.